Stockscreener 앱 받기
1.33
2.21%
-0.03
시간 외 거래:
1.33
전일 마감가:
$1.36
열려 있는:
$1.33
하루 거래량:
1.27M
Relative Volume:
0.55
시가총액:
$483.32M
수익:
$1.21M
순이익/손실:
$-177.12M
주가수익비율:
-1.6625
EPS:
-0.8
순현금흐름:
$-162.37M
1주 성능:
-2.92%
1개월 성능:
-5.67%
6개월 성능:
+95.42%
1년 성능:
+10.37%
1일 변동 폭
$1.3201
$1.39
1주일 범위
$1.3031
$1.40
52주 변동 폭
$0.2836
$1.66
렉시콘 파마슈티컬스 Stock (LXRX) Company Profile
명칭
Lexicon Pharmaceuticals Inc
전화
(281) 863-3000
주소
2445 TECHNOLOGY FOREST BLVD., THE WOODLANDS
LXRX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LXRX
Lexicon Pharmaceuticals Inc
|
1.33 | 494.22M | 1.21M | -177.12M | -162.37M | -0.80 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -906.14M | -6.1812 |
렉시콘 파마슈티컬스 Stock (LXRX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-03-05 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-06-17 | 개시 | H.C. Wainwright | Buy |
| 2024-04-30 | 개시 | Leerink Partners | Outperform |
| 2023-03-07 | 개시 | Jefferies | Hold |
| 2022-08-12 | 개시 | Piper Sandler | Overweight |
| 2021-01-29 | 업그레이드 | JP Morgan | Underweight → Neutral |
| 2021-01-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2020-12-08 | 업그레이드 | Citigroup | Neutral → Buy |
| 2020-11-18 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2019-12-11 | 다운그레이드 | Gabelli & Co | Buy → Hold |
| 2019-11-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-09-11 | 업그레이드 | Gabelli & Co | Hold → Buy |
| 2019-07-29 | 다운그레이드 | Stifel | Buy → Hold |
| 2019-03-25 | 업그레이드 | Gabelli & Co | Sell → Hold |
| 2018-07-31 | 재확인 | Stifel | Buy |
| 2018-02-23 | 다운그레이드 | Needham | Buy → Hold |
| 2018-02-14 | 다운그레이드 | JP Morgan | Neutral → Underweight |
| 2017-03-01 | 재확인 | H.C. Wainwright | Buy |
| 2017-03-01 | 재확인 | Wedbush | Outperform |
| 2016-10-07 | 개시 | H.C. Wainwright | Buy |
| 2016-08-05 | 재확인 | Wedbush | Outperform |
| 2016-08-02 | 개시 | Citigroup | Buy |
| 2016-03-02 | 재확인 | Wedbush | Outperform |
| 2015-11-09 | 재확인 | Wedbush | Outperform |
| 2015-09-28 | 업그레이드 | Gabelli & Co | Sell → Hold |
| 2015-09-18 | 다운그레이드 | Gabelli & Co | Hold → Sell |
| 2015-08-10 | 다운그레이드 | JP Morgan | Overweight → Neutral |
모두보기
렉시콘 파마슈티컬스 주식(LXRX)의 최신 뉴스
Lexicon (NASDAQ: LXRX) to present sotagliflozin data in HFpEF, HCM, and T2D at AHA 2025 - Stock Titan
What MACD signals say about Lexicon Pharmaceuticals Inc.Earnings Overview Summary & Fast Momentum Stock Entry Tips - newser.com
What the charts say about Lexicon Pharmaceuticals Inc. today2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Applying Wyckoff theory to Lexicon Pharmaceuticals Inc. stockGlobal Markets & Free Reliable Trade Execution Plans - newser.com
Why Lexicon Pharmaceuticals Inc. stock remains a top recommendation2025 Top Gainers & Daily Chart Pattern Signal Reports - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for growth ETFsJuly 2025 Setups & Accurate Trade Setup Notifications - newser.com
Published on: 2025-11-02 14:31:16 - newser.com
What candlestick patterns are forming on Lexicon Pharmaceuticals Inc.2025 Big Picture & Safe Entry Zone Identification - newser.com
Using data tools to time your Lexicon Pharmaceuticals Inc. exitQuarterly Market Review & Real-Time Sentiment Analysis - newser.com
Is Lexicon Pharmaceuticals Inc. stock attractive for hedge fundsQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-31 04:02:24 - newser.com
Lexicon Pharmaceuticals, Inc. (LXRX) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Lexicon Pharmaceuticals to Report Third Quarter 2025 Financial Results on November 6, 2025 - The Manila Times
Lexicon (NASDAQ: LXRX) sets Nov. 6 call for third quarter results at 8:30 a.m. ET - Stock Titan
Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX) Q4 2024 Earnings Call Transcript - MSN
How analysts rate Lexicon Pharmaceuticals Inc. stock todayLayoff News & Free Real-Time Volume Trigger Notifications - Fundação Cultural do Pará
Is Lexicon Pharmaceuticals Inc. stock a defensive play in 2025Weekly Earnings Recap & Free Accurate Trade Setup Notifications - fcp.pa.gov.br
Weiss Ratings Reaffirms "Sell (D-)" Rating for Lexicon Pharmaceuticals (NASDAQ:LXRX) - MarketBeat
렉시콘 파마슈티컬스 (LXRX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.45%
0.86%
자본화:
|
볼륨(24시간):